101.7 FM
88.1HD2
8.85 c101.7 FM
88.1HD2
Health Canada says it can't provide a definite timeline for when it will wrap up its review of AstraZeneca COVID-19 vaccine
BY , Dec 30, 2020 8:31 PM - REPORT AN ERROR
A healthcare worker talks with people as they wait to be tested for COVID-19 at a clinic in Montreal, Sunday, Dec. 27, 2020. THE CANADIAN PRESS/Graham Hughes
Health Canada says it can't provide a definite timeline for when it will wrap up its review of the COVID-19 vaccine manufactured by AstraZeneca.
This morning, Britain approved the use of the drug created by the UK based drugmaker and Oxford University.
Health Canada says it needs more information before it can complete its analysis.
Britain became the first country to authorize AstraZeneca’s inexpensive, easy-to-handle COVID-19 vaccine Wednesday, gaining another weapon against the virus amid a resurgence so severe that the government extended lockdowns to three-quarters of England’s population.
The country also changed course by deciding to dispense the first dose of its vaccines to as many people as possible right away, to give them at least some protection.
Until now, authorities have been holding large amounts of vaccine in reserve, to make sure those who receive the first dose get the required second one on time.
Share on
Related News
Sign up for the newsletter
We'll deliver best of entertainment right into your inboxWe love to hear from our listeners, so feel free to send us message
Message us on whatsapp
